Affordability, pharmaceuticals

The identification and characterization of cell culture systems (e.g., Caco-2-cells) that mimic in vivo biological barriers (e.g., intestinal mucosa) have afforded pharmaceutical scientists the opportunity to rapidly and efficiently assess the permeability of drugs through these barriers in vitro. The results generated from these types of in vitro studies are generally expressed as effective permeability coefficients (Pe). If Pe is properly corrected to account for the barrier effects of the filter (PF) and the aqueous boundary layer (PAbl) as previously described in Section II.C, the results provide the permeability coefficient for the cell monolayer... 

The selection of pharmaceutical products based on a national formulary or on the essential medicines list is recommended. WHO s Model Formulary (15 and Model Essential Medicines List 4) identify the most cost-effective and affordable pharmaceutical products to treat prevailing health problems. They are updated regularly and are made freely available for adaptation by countries. The health systems of many industrialized and developing countries have used the essential medicines concept for decades to use existing resources effectively. Because the use of a national formulary reduces the number of products used, supply management activities and inventorycarrying costs are minimized. 

One remarkable achievement of red biotechnology was that, although costs in drug development exploded, the costs for process development of manufacturing processes for proteins were reduced over time. This should also be the goal for small molecule pharmaceuticals, which represent the majority of active pharmaceutical ingredients (APIs). The sustainable production of affordable pharmaceuticals and health-care products should be a priority for biotechnology These objectives are... 

The Ley group also investigated the PS-base/tosyl chloride methodology developed by Brain (see above. Scheme 8) for the synthesis of 2-aminooxadiazoles from semicarbazides, especially with a view to directly synthesize 2-aminosulfonamide substituted 1,3,4-oxadiazoles, a compound class of interest for agrochemical and pharmaceutical apphcations (Scheme 10) [71]. In this case, the choice of the supported base was crucial for the result of the reaction weak bases (PS-DIEA, PS-NMM) could still afford the cyclized 2-aminooxadiazole product, but could not efficiently... 

Lactide/glycolide polymers have been investigated for delivery of agents in applications outside the pharmaceutical field. For example, the microbiocidal properties of chlorine dioxide disinfectants have been improved by formulating a long-acting chlorine dioxide system based on lactide/glycolide copolymers. Blends of microspheres based on 50 50 and 87 13 copolymers were developed to afford the release of chlorine dioxide over several months (114). 

The new major challenge that the pharmaceutical industry is facing in the discovery and development of new drugs is to reduce costs and time needed from discovery to market, while at the same time raising standards of quality. If the pharmaceutical industry cannot find a solution to reduce both costs and time, then its whole business model will be jeopardized The market will hardly be able, even in the near future, to afford excessively expensive drugs, regardless of their quality. 

Substituted 1-hydroxy cyclohexane-1-carboxyhc acids, which could be prepared from the corresponding cyanohydrins by acid hydrolysis as described above, are important as pharmaceuticals and plant-protective agents. Although the compounds derived from 2- and 3-cyclohexanones have two stereogenic centers, stereoselective syntheses of these interesting products have been published only very recently. " Completely unexpected are the results of HNL-catalyzed additions to 4-substituted cyclohexanones, which do not possess a prochiral center. The (R)-PaHNL-catalyzed addition affords almost exclusively fran -isomers, whereas with (5 )-MeHNL cA-addition is favored (Table 4). ... 

Next, reductive amination (step 4 in scheme 1) was exchanged with copper catalyzed palladium coupling (step 2 in scheme 1). Atomic absorption analysis for palladium in RWJ-26240 samples prepared by scheme 2 indicated that the level of palladium was reduced to an acceptable level. This improvement may be due to the two reduction steps subsequent to the use of palladium in scheme 2.177 The final major modification to the reaction scheme was the substitution of NaBH4 for NaBH3CN. The yield of product (60%) was determined by HPLC (Method 2). Reductive alkylation with formalin/NaBH4 afforded a pharmaceutically acceptable drug substance. 

Today, multi-parallel synthesis lies at the forefront of organic and medicinal chemistry, and plays a major role in lead discovery and lead optimization programs in the pharmaceutical industry. The first solid-phase domino reactions were developed by Tietze and coworkers [6] using a domino Knoevenagel/hetero-Diels-Alder and a domino Knoevenagel/ene protocol. Reaction of solid-phase bound 1,3-dicarbonyl compounds such as 10-22 with aldehydes and enol ethers in the presence of piperidinium acetate led to the 1-oxa-1,3-butadiene 10-23, which underwent an intermolecular hetero-Diels-Alder reaction with the enol ethers to give the resin-bound products 10-24. Solvolysis with NaOMe afforded the desired dihydro-pyranes, 10-25 with over 90 % purity. Ene reactions have also been performed in a similar manner [7]. 

Screening a large pharmaceutical library derived from eukaryotic drug discovery programs afforded pyridopyrimidine 2, a lead targeting the... 

Treatment of 2-benzoylpyridine 81 with p-toluene-sulfonamide gave 1-amino-2-benzoylpyridinium tosylate 82 (X = OTs), which was cyclized with formamide in the presence of triethylamine hydrobromide to give 83 (82FRP2486942). The reaction of the perchlorate 82 (X = C104) with urea in polyphosphoric acid afforded 3-hydroxy-l-phenylpyrido[2,l-/][l,2,4]triazinium perchlorate 84. Treatment of this salt with base led to the zwitterionic l-phenylpyrido[2,l-/][l,2,4]triazin-5-ium-3-olate 85 (86JHC375). Pharmaceutical compositions contain 83 (82FRP2486942). 

The cost implications of pharmacogenomics, both at the individual and societal levels, are the subject of considerable debate, as discussed in detail in Chapter 12 of this book. One possible scenario is that pharmacogenomic-based medications will be more expensive and therefore not as widely available as pharmaceutical products intended for wider distribution (Rai, 2001 Rothstein and Epps, 2001). We attempted to determine whether members of the public believed that they would be able to afford these new pharmaceutical products. To do so, we asked the following question (Question 9) ... 

---